Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.
Quick Stats
Feb 02, 202659.8
AI Score
HOLD1.75
Volume Ratio
Mar 16, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
GYRE Stock Summary
Last updated Feb 02, 2026
GYRE is currently trading at $8.21, positioned above its 200-day moving average of $8.01, indicating a long-term uptrend. The stock has a 52-week range of $6.11 to $13.75.
Technical Analysis: The 50-day moving average stands at $7.64, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 58.211, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.206, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates GYRE at 59.8/100 with a HOLD recommendation.
GYRE (Gyre Therapeutics, Inc. Common Stock) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 58.211 |
| CMF (20) | 0.206 |
| ROC (10) | 6.901 |
| ADX (14) | 15.533 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.177 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -19.71 |
| MFI (14) | 78.431 |
GYRE Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
GYRE Price vs Max Options Open Interest
GYRE Max Change In Options Open Interest
GYRE Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GYRE Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GYRE Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GYRE Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Gyre Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
GYRE Moving Averages Analysis
Gyre Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Feb 02, 2026
Gyre Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026
GYRE (Gyre Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 8.06 |
| 20 | 7.82 |
| 30 | 7.59 |
| 50 | 7.64 |
| 100 | 7.7 |
| 200 | 8.01 |
GYRE Fundamental Analysis
| P/E (Forward) | 80.6452 |
| P/E (Trailing) | 202.25 |
| Market Cap ($) | 779.3 million |
| Earnings/Share ($) | 0.04 |
| Net Proft Margin (%) | 0.062 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.15 |
| EPS Estimate Next Year ($) | 0.1833 |
| WallStreet Target Price ($) | 18 |
| Most Recent Quarter |